deferoxamine has been researched along with Infections, Coronavirus in 2 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Li, Y | 2 |
Bao, Y | 1 |
Duan, X | 1 |
Dong, S | 1 |
Lin, J | 1 |
Chang, X | 1 |
Tan, Y | 1 |
Zhang, H | 1 |
Shan, H | 1 |
Abobaker, A | 1 |
2 other studies available for deferoxamine and Infections, Coronavirus
Article | Year |
---|---|
RSL3 Inhibits Porcine Epidemic Diarrhea Virus Replication by Activating Ferroptosis.
Topics: Acetylcysteine; Animals; Chlorocebus aethiops; Coronavirus Infections; Deferoxamine; Diarrhea; Ferro | 2023 |
Can iron chelation as an adjunct treatment of COVID-19 improve the clinical outcome?
Topics: Animals; Anti-Inflammatory Agents; Antibodies, Neutralizing; Antiviral Agents; B-Lymphocytes; Betaco | 2020 |